Clinical courses and prognoses of pulmonary sarcoidosis

Current Opinion in Pulmonary Medicine

Volumn 5, Issue 5, 1999, Pages 293-298

  Nagai, Sonoko ^a   Shigematsu, Michio ^a   Hamada, Kunio ^a   Izumi, Takateru ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CLASSIFICATION; DISEASE PREDISPOSITION; FORECASTING; GENETICS; HUMAN; PATHOPHYSIOLOGY; PROGNOSIS; REVIEW; SARCOIDOSIS; THORAX DISEASE; TREATMENT OUTCOME;

DISEASE SUSCEPTIBILITY; FORECASTING; HUMANS; PROGNOSIS; SARCOIDOSIS; SARCOIDOSIS, PULMONARY; THORACIC DISEASES; TREATMENT OUTCOME;

EID: 0033194462     PISSN: 10705287     EISSN: None     Source Type: Journal    
DOI: 10.1097/00063198-199909000-00005     Document Type: Article

References (28)

1. Berlin M, Fogdell-Hahn A, Olerup O, Eklund A, Grunewald J: HLA-DR predicts the prognosis in Scandinavian patients with pulmonary sarcoidosis. Am J Respir Crit Care Med 1997, 156:1601-1605.
2. Maliarik MJ, Chen KM, Major ML, Sheffer RG, Popovich J Jr, Rybicki BA, et al.: Analysis of HLA-DPB1 polymorphisms in African-Americans with sarcoidosis. Am J Respir Crit Care Med 1998, 158:111-114. The author found that the DNA sequences of HLA-DPB1 exon 2 associated with an increased risk for sarcoidosis, were different from those of Val36 and Asp55.
3. Seitzer U, Swider C, Stuber F, Suchnicki K, Lange A, Richter E, et al.: Tumor necrosis factor alpha promoter gene polymorphism in sarcoidosis. Cytokine 1997, 9:787-790. Gene frequencies of the TNFα gene variation were significantly different within the clinical forms of sarcoidosis.
4. Kawakami Y, Munakata M, Yamaguchi E, Furuya K, Matsuda T: Molecular studies of bronchial asthma, sarcoidosis and angiotensin converting enzyme inhibitor-induced cough. Respirology 1998, 3:45-49.
5. Siltzbach LE: Sarcoidosis: clinical features and management. Med Clin North Am 1967, 51:483-502.
6. Hamada K, Nagai S, Tsutsumi T, Izumi T: Ionized calcium and 1,25-dihydroxyvitamin D concentration in serum of patients with sarcoidosis. Eur Respir J 1998, 11:1015-1020.
7. Rizzato G: Clinical impact of bone and calcium metabolism changes in sarcoidosis. Thorax 1998, 53:425-429.
8. Pettersson T: Rheumatic features of sarcoidosis. Curr Opin Rheumatol 1998, 10:73-78.
9. Nakamura H, Genma R, Mikami T, Kitahara A, Natsume H, Andoh S, et al.: High incidence of positive autoantibodies against thyroid peroxidase and thyroglobulin in patients with sarcoidosis. Clin Endocrinol Oxf 1997, 46:467-472. The author showed a remarkably higher incidence of thyroid autoantibodies in patients with sarcoidosis, as well as a higher prevalence of Hashimoto's thyroiditis compared to previous reports.
10. Sakurai Y, Nakajima M, Kamisue S, Nishimura Y, Ueda T, Miyagawa S, et al.: Preschool sarcoidosis mimicking juvenile rheumatoid arthritis: the significance of gallium scintigraphy and skin biopsy in the differential diagnosis. Acta Paediatr Jpn 1997, 39:74-78.
11. Hughes P, McGavin CR: Sarcoidosis and primary biliary cirrhosis with coexisting myositis. Thorax 1997, 52:201-202.
12. Takahashi T, Munakata M, Homma Y, Kawakami Y: Association of progressive systemic sclerosis with pulmonary sarcoidosis. Just a chance occurrence? Intern Med 1997, 36:435-438.
13. Lois M, Roman J, Holland W, Agudelo C: Coexisting Sjogren's syndrome and sarcoidosis in the lung. Semin Arthritis Rheum 1998, 28:31-40.
14. Cancrini C, Angelini F, Colavita M, Cortis E, Chini L, Mammone F, et al.: Erythema nodosum: a presenting sign of early onset sarcoidosis. Clin Exp Rheumatol 1998, 16:337-339.
15. Nagai S, Izumi T: Bronchoalveolar lavage fluid cell findings in patients with extrathoracic lesions. Seminar in Resp Med 1992, 13:393-398.
16. Neville E, Walker AN, James DG: Prognostic factors predicting the outcome of sarcoidosis. An analysis of 818 patients. Q J Med 1983, 205:525-538.
17. Robinson LR, Brownsberger R, Raghu G: Respiratory failure and hypoventilation secondary to neurosarcoidosis. Am J Respir Crit Care Med 1998, 157:1316-1318. Phrenic neuropathy and peripheral polyneuropathy secondary to neurosarcoidosis are discussed as a cause of respiratory failure.
18. Mana J, Salazar A, Manresa F: Clinical predicting of activity in sarcoidosis: a multivariate analysis of 193 cases. Respiration 1994, 61:219-225.
19. Fink CW, Cimaz R: Early onset sarcoidosis: not a benign disease. J Rheumatol 1997, 24:174-177. The clinical picture of 6 patients with sarcoidosis of the early-onset type is described. Severe complications of the disease such as blindness, growth retardation, heart involvement, and renal failure were found during a long follow-up. Pulmonary involvement was present only in one patient, late in the disease course.
20. Katz S: Clinical presentation and natural history of sarcoidosis. In Sarcoidosis and other granulomatous diseases of the lung. Edited by Fanburg BL. New York:Marcel Dekker; 1983:3-36.
21. Vestbo J, Viskum K: Respiratory symptoms at presentation and long-term vital prognosis in patients with pulmonary sarcoidosis. Sarcoidosis 1994, 11:123-125.
22. Baughman RP, Winget DB, Bowen EH, Lower EE: Predicting respiratory failure in sarcoidosis patients. Sarcoidosis Vasc Diffuse Lung Dis 1997, 14:154-158.
23. Winterbauer RH, Kirtland SH, Corley DE: Treatment with corticosteroids. Clin Chest Med 1997, 18:843-851.
24. Gottlieb JE, Israel HL, Steiner RM, Triolo J, Patrick H: Outcome in sarcoidosis. The relationship of relapse to corticosteroid therapy. Chest 1997, 111:623-631. There was a 74% relapse rate in the induced remission group, in contrast to only an 8% relapse rate in the spontaneous remission group.
25. Mikuniya T, Nagai S, Morita K, Mio T, Satake N, Izumi T: Lipocortin I gene expression is higher in blood monocytes than in BAL fluid macrophages in patients with pulmonary sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 1997, 15:38-43.
26. Muers MF, Middleton WG, Gibson GJ, Prescott RJ, Mitchell DN, Connolly CK, et al.: A simple radiographic scoring method for monitoring pulmonary sarcoidosis: relations between radiographic scores, dyspnea grade and respiratory function in the British Thoracic Society Study of Long-Term Corticosteroid Treatment. Sarcoidosis Vasc Diffuse Lung Dis. 1997, 14:46-56.
27. Walker S, Mikhail G, Banner N, Partridge J, Khaghani A, Burke M, et al.: Medium term results of lung transplantation for end stage pulmonary sarcoidosis, Thorax 1998, 53:281-284
28. Pigula FA, Griffith BP, Zenati MA, Dauber JH, Yousem SA, Keenan RJ: Lung transplantation for respiratory failure resulting from systemic disease. Ann Thoracic Surg 1997, 64: 1630-1634.